Buy or sell Renovia stock pre IPO via an EquityZen fund

EquityZen is a marketplace for shares of proven pre IPO tech companies

Renovia Stock

Renovia produces medical devices that seek to alleviate urinary incontinence in women.

About Renovia Stock

Renovia produces medical devices that seek to alleviate incontinence in women. It offers diagnostic and therapeutic devices for women with pelvic floor disorders. Marc Beer, Ramon Iglesias, and Yolanda Lorié founded Renovia in 2016. Its headquarters is in Boston in Massachusetts.

Funding History

January 2017	$8.0M
August 2018	$32.3M
August 2018	$10.0M

Management

CIO

Ramon Iglesias

CSO

José Bohorquez

CCO

William Dull

CEO & Chairman

Marc Beer

Vice President of Medical Affairs

Jessica McKinney

Other Companies

Learn More

Alumis

Alumis is a precision medicine company focused on the discovery, development and treatment of autoimmune disorders.

1Age (years)

$270MTotal Funding

Learn More

Intarcia Therapeutics

Intarcia Therapeutics is a biopharmaceutical company developing therapies for diseases that require long-term chronic treatment.

Lab-quality diagnostics for anyone, anywhere, at any time.

Somatus is a healthcare company that partners with health plans, health systems, nephrology, and primary care groups.

6Age (years)

$465MTotal Funding

EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Trending Companies

Join 280K+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

Why EquityZen?

EquityZen helps investors to access private companies and their employees to sell shares.

Request Access

Investment opportunities posted on this website are "private placements" of securities that are not publicly traded, are subject to holding period requirements, and are intended for investors who do not need a liquid investment. Investing in private companies may be considered highly speculative and involves a high degree of risk, including the risk of substantial loss of investment. Investors must be able to afford the loss of their entire investment. See our Risk Factors for a more detailed explanation of the risks involved by investing through EquityZen’s platform.

EquityZen Securities LLC (“EquityZen Securities”) is a subsidiary of EquityZen Inc. EquityZen Securities is a broker/dealer registered with the Securities Exchange Commission and is a FINRA/SIPC member firm.

Equity securities are offered through EquityZen Securities. Check the background of this firm on FINRA’s BrokerCheck.

EquityZen.com is a website operated by EquityZen Inc. ("EquityZen"). By accessing this site and any pages thereof, you agree to be bound by our Terms of Use.
EquityZen and logo are trademarks of EquityZen Inc. Other trademarks are property of their respective owners.
© 2022 EquityZen Inc. All rights reserved.